These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36906668)

  • 1. Impact of 2021 ESC Guidelines for Cardiovascular Disease Prevention on Hypertensive Patients Risk: Secondary Analysis of Save Your Heart Study.
    Del Pinto R; Giua C; Keber E; Grippa E; Tilotta M; Ferri C
    High Blood Press Cardiovasc Prev; 2023 Mar; 30(2):167-173. PubMed ID: 36906668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCORE model underestimates cardiovascular risk in hypertensive patients: results of the Polish Hypertension Registry.
    Szyndler A; Kucharska WA; Dubiela-D Browska AE; Olszanecka A; Widecka J; B Czkiewicz MA; Widecka K; Galas GY; Chlebi Ska I; Sakiewicz W; Gaciong Z; Widecka K; Januszewicz A; Kawecka-Jaszcz K; Narkiewicz K;
    Blood Press; 2011 Dec; 20(6):342-7. PubMed ID: 21675828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide cardiovascular risk categorization: applying the European Society of Cardiology guidelines to the Swedish National Diabetes Register.
    Eliasson B; Ekelund J; Holmberg CN; Wolden ML; Matthiessen KS; James S
    Eur J Prev Cardiol; 2023 May; 30(7):546-551. PubMed ID: 36567502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.
    Pavlović J; Greenland P; Deckers JW; Kavousi M; Hofman A; Ikram MA; Franco OH; Leening MJ
    Eur J Prev Cardiol; 2018 Mar; 25(4):420-431. PubMed ID: 29171772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Society of Cardiology: Cardiovascular Disease Statistics 2019.
    Timmis A; Townsend N; Gale CP; Torbica A; Lettino M; Petersen SE; Mossialos EA; Maggioni AP; Kazakiewicz D; May HT; De Smedt D; Flather M; Zuhlke L; Beltrame JF; Huculeci R; Tavazzi L; Hindricks G; Bax J; Casadei B; Achenbach S; Wright L; Vardas P;
    Eur Heart J; 2020 Jan; 41(1):12-85. PubMed ID: 31820000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-state analysis of hypertension and mortality: application of semi-Markov model in a longitudinal cohort study.
    Ramezankhani A; Blaha MJ; Mirbolouk MH; Azizi F; Hadaegh F
    BMC Cardiovasc Disord; 2020 Jul; 20(1):321. PubMed ID: 32631245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
    Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data.
    Bundy JD; Mills KT; Chen J; Li C; Greenland P; He J
    JAMA Cardiol; 2018 Jul; 3(7):572-581. PubMed ID: 29800138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
    Son JS; Choi S; Kim K; Kim SM; Choi D; Lee G; Jeong SM; Park SY; Kim YY; Yun JM; Park SM
    JAMA; 2018 Nov; 320(17):1783-1792. PubMed ID: 30398603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the HellenicSCORE (a Calibration of the ESC SCORE Project) Regarding 10-Year Risk of Fatal Cardiovascular Disease in Greece.
    Panagiotakos DB; Georgousopoulou EN; Fitzgerald AP; Pitsavos C; Stefanadis C
    Hellenic J Cardiol; 2015; 56(4):302-8. PubMed ID: 26233769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage 1 hypertension, but not elevated blood pressure, predicts 10-year fatal and non-fatal CVD events in healthy adults: the ATTICA Study.
    Critselis E; Chrysohoou C; Kollia N; Georgousopoulou EN; Tousoulis D; Pitsavos C; Panagiotakos DB;
    J Hum Hypertens; 2019 Apr; 33(4):308-318. PubMed ID: 30742050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
    JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.
    Mortensen MB; Tybjærg-Hansen A; Nordestgaard BG
    JAMA Cardiol; 2022 Aug; 7(8):836-843. PubMed ID: 35793078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citizens and family doctors facing awareness and management of traditional cardiovascular risk factors: results from the Global Cardiovascular Risk Reduction Project (Help Your Heart Stay Young Study).
    Celentano A; Panico S; Palmieri V; Guillaro B; Brancati C; Di Palma Esposito N; Arezzi E; Setola C; Piccinocchi G; Canfora G; Rubba P; Di Minno G; Mancini M
    Nutr Metab Cardiovasc Dis; 2003 Aug; 13(4):211-7. PubMed ID: 14650353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-Attributable Risk for Cardiovascular Disease Associated With Hypertension in Black Adults.
    Clark D; Colantonio LD; Min YI; Hall ME; Zhao H; Mentz RJ; Shimbo D; Ogedegbe G; Howard G; Levitan EB; Jones DW; Correa A; Muntner P
    JAMA Cardiol; 2019 Dec; 4(12):1194-1202. PubMed ID: 31642869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the proportion of Danes at high risk of fatal cardiovascular disease.
    Holm AS; Olsen GS; Borglykke A; Jørgensen T
    Scand J Public Health; 2011 Aug; 39(6):571-6. PubMed ID: 21737477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk assessment in hypertensive patients with tests recommended by the European Guidelines on Hypertension.
    Gómez-Marcos MA; González-Elena LJ; Recio-Rodríguez JI; Rodríguez-Sánchez E; Magallón-Botaya R; Muñoz-Moreno MF; Patino-Alonso MC; García-Ortiz L
    Eur J Prev Cardiol; 2012 Jun; 19(3):515-22. PubMed ID: 21450575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.